The Effect of Sleep Loss on Emotion Regulation
The Impact of Insufficient Sleep and Insomnia Disorder on Behavioral and Neural Markers of Emotion Regulation
1 other identifier
interventional
90
1 country
1
Brief Summary
The study is designed to investigate the impact of three nights of sleep restricted to 4 hours per night, on the processing and regulation of emotional information compared to Insomnia Disorder and control. The investigators will address and attempt to answer two questions. (i) How do three nights of reduced sleep or a diagnosis of Insomnia Disorder affect the processing and regulation of emotional information compared to typical, undisturbed sleep? (ii) What overlapping and distinct neural mechanisms are engaged and associated with behavioral effects when attempting to process and regulate emotions in a sleep restricted state or with a clinical diagnosis of Insomnia Disorder? This study will investigate sleep's role in emotion processing and regulation. The findings will help further understanding of the role of sleep in healthy emotional functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2022
CompletedFirst Posted
Study publicly available on registry
May 26, 2022
CompletedStudy Start
First participant enrolled
May 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
April 14, 2026
April 1, 2026
3.9 years
May 20, 2022
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Baseline Emotional Regulation Task with Strategy
Baseline behavioral ratings to emotional stimuli with emotion regulation strategies
Day 1
Baseline Emotional Regulation Task without Strategy
Baseline behavioral ratings to emotional stimuli without emotion regulation strategies
Day 1
Reassessment of the Emotional Regulation Task with Strategy Baseline behavioral ratings to emotional stimuli with or without emotion regulation strategies
Behavioral ratings to emotional stimuli with emotion regulation strategies following normal sleep or sleep restriction
one test in a 3-6 day window
Reassessment of the Emotional Regulation Task without Strategy Baseline behavioral ratings to emotional stimuli with or without emotion regulation strategies
Behavioral ratings to emotional stimuli without emotion regulation strategies following normal sleep or sleep restriction
one test in a 3-6 day window
Secondary Outcomes (1)
Functional Magnetic Resonance Imaging (fMRI)
one test in a 3-6 day window
Study Arms (3)
Normal Sleep
NO INTERVENTIONNormal Sleep - Healthy participants are permitted normal nights of polysomnography or actigraphy recorded sleep before participating in an emotion regulation task during functional Magnetic Resonance Imaging (fMRI) scanning
Sleep Restriction
ACTIVE COMPARATORHealthy Participants are sleep restricted to 4 hours of sleep for 3 consecutive days before participating in an emotion regulation task during functional Magnetic Resonance Imaging (fMRI) scanning
Patients with Insomnia Disorder
NO INTERVENTIONPatients with Insomnia Disorder will also be recruited and will be permitted normal nights of polysomnography or actigraphy recorded sleep before participating in an emotion regulation task during functional Magnetic Resonance Imaging (fMRI) scanning
Interventions
Eligibility Criteria
You may qualify if:
- willing and able to follow the protocol
- willing to refrain from alcohol and recreational drugs for the duration of the protocol
- normal or corrected to normal vision is required
You may not qualify if:
- left-handedness or ambidexterity
- the use of any drugs that could affect either sleep or cognitive functioning (e.g., prescription sleeping pills or antidepressants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janet M Mullington, PhD
Beth Israel Deaconess Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology in the Department of Psychiatry
Study Record Dates
First Submitted
May 20, 2022
First Posted
May 26, 2022
Study Start
May 11, 2023
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
We are developing our institutional data sharing plan